Sept 25 (Reuters) – ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings. The San
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
IRAN'S PRESIDENT SAYS TEHRAN AGREES ON NEED TO RETURN TO ISLAMABAD UNDERSTANDING, HONOR COMMITMENTS
IRAN'S PRESIDENT SAYS TEHRAN AGREES ON NEED TO RETURN TO ISLAMABAD UNDERSTANDING, HONOR COMMITMENTS (The…
Anthropic investor Lonsdale says AI firms stoking fear to sway policy
By Joe Brock AUSTIN, Sept 25 (Reuters) - Joe Lonsdale, an investor in Anthropic and the…
REUTERS NEXT-FTC chair suggests AI developers should be liable for conduct of agents
By Jody Godoy AUSTIN, Sept 25 (Reuters) - US Federal Trade Commission Chairman Andrew Ferguson…
